These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 406677

  • 1. The clinical toxicity of anticancer drugs and its prediction.
    Creaven PJ, Mihich E.
    Semin Oncol; 1977 Jun; 4(2):147-63. PubMed ID: 406677
    [No Abstract] [Full Text] [Related]

  • 2. Toxicology of anticancer drugs.
    Guarino AM.
    Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105
    [No Abstract] [Full Text] [Related]

  • 3. Preclinical toxicology of anticancer agents.
    Schein PS.
    Cancer Res; 1977 Jun; 37(6):1934-7. PubMed ID: 404039
    [No Abstract] [Full Text] [Related]

  • 4. Toxicology and pharmacology of the nitrosoureas.
    Oliverio VT.
    Cancer Chemother Rep 3; 1973 May; 4(3):13-20. PubMed ID: 4201308
    [No Abstract] [Full Text] [Related]

  • 5. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome.
    Mirsalis JC, Schindler-Horvat J, Hill JR, Green CE, Mitoma C, Tomaszewski JE, Tyson CA, Donohue SJ.
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436
    [Abstract] [Full Text] [Related]

  • 6. Preclinical study of antitumor compounds.
    Syrkin AB.
    Natl Cancer Inst Monogr; 1977 Mar; (45):255-9. PubMed ID: 927492
    [No Abstract] [Full Text] [Related]

  • 7. [Side effect of antineoplastic agents and its prevention].
    Takemasa Y.
    Naika; 1971 Oct; 28(4):685-9. PubMed ID: 4943167
    [No Abstract] [Full Text] [Related]

  • 8. Phase I study of anguidine administered weekly.
    Belt RJ, Haas CD, Joseph U, Goodwin W, Moore D, Hoogstraten B.
    Cancer Treat Rep; 1979 Oct; 63(11-12):1993-5. PubMed ID: 526932
    [Abstract] [Full Text] [Related]

  • 9. [Chemotherapy of solid tumors].
    Zwaveling A.
    Ned Tijdschr Geneeskd; 1973 Jun 09; 117(23):880-5. PubMed ID: 4131583
    [No Abstract] [Full Text] [Related]

  • 10. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF, Macias RI, Izco-Basurko I, de La Fuente A, Pascual MJ, Criado JM, Monte MJ, Yajeya J, Marin JJ.
    J Pharmacol Exp Ther; 2001 Jun 09; 297(3):1106-12. PubMed ID: 11356935
    [Abstract] [Full Text] [Related]

  • 11. [Side effects of antineoplastic treatment and interference with general anesthesia].
    Metahni MK, Kaddour C, Bousoffara M, Skandrani L.
    Tunis Med; 1996 Jan 09; 74(1):7-15. PubMed ID: 9507307
    [No Abstract] [Full Text] [Related]

  • 12. [Cardiotoxicity of antineoplastic drugs].
    Drzewoski J, Kasznicki J.
    Acta Haematol Pol; 1992 Jan 09; 23(2):79-86. PubMed ID: 1488864
    [Abstract] [Full Text] [Related]

  • 13. [Synopsis of the hydantoins].
    Gottwald W.
    Fortschr Neurol Psychiatr Grenzgeb; 1969 Nov 09; 37(11):573-648. PubMed ID: 4901428
    [No Abstract] [Full Text] [Related]

  • 14. The development of new cancer drugs: a joint venture in public policy by the National Cancer Institute and Food and Drug Administration.
    Crout JR.
    Cancer Treat Rep; 1982 Sep 09; 66(9):1705-7. PubMed ID: 6811133
    [No Abstract] [Full Text] [Related]

  • 15. Current dosage and schedule issues in the development of paclitaxel (Taxol).
    Arbuck SG, Canetta R, Onetto N, Christian MC.
    Semin Oncol; 1993 Aug 09; 20(4 Suppl 3):31-9. PubMed ID: 8102016
    [Abstract] [Full Text] [Related]

  • 16. [Kallikrein and cell proliferation. Review].
    Huber P, Schütte B, Lindner J.
    Med Welt; 1981 Dec 25; 32(51-52):1933-40. PubMed ID: 7035784
    [No Abstract] [Full Text] [Related]

  • 17. Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.
    Gralla EJ, Coleman GL, Jonas AM.
    Cancer Chemother Rep 3; 1974 Sep 25; 5(1):1-7. PubMed ID: 4213305
    [No Abstract] [Full Text] [Related]

  • 18. First dose of potential new medicines to humans: how animals help.
    Greaves P, Williams A, Eve M.
    Nat Rev Drug Discov; 2004 Mar 25; 3(3):226-36. PubMed ID: 15031736
    [Abstract] [Full Text] [Related]

  • 19. Preclinical toxicologic evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in mice, dogs, and monkeys.
    Henry MC, Port CD, Levine BS.
    Cancer Treat Rep; 1980 Mar 25; 64(8-9):855-60. PubMed ID: 6893811
    [Abstract] [Full Text] [Related]

  • 20. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER, Lambert AL, Smith AC, Page JG, Johnson WD, McCormick DL, Brown AP, Levine BS, Covey JM, Egorin MJ, Eiseman JL, Holleran JL, Sausville EA, Tomaszewski JE.
    Cancer Chemother Pharmacol; 2005 Dec 25; 56(6):637-47. PubMed ID: 15986212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.